News Consumer News FDA OKs Farxiga for Heart Failure With Reduced Ejection Fraction WEDNESDAY, May 6, 2020 — The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday. Farxiga is the first approved sodium-glucose cotransporter 2 inhibitor… Read More »
While the coronavirus (COVID-19) pandemic has halted the cadence of everyday life for just about everyone, the world is now beginning to adjust. We’re all handling the challenges of social distancing and self-isolation differently—but that doesn’t mean that we have to go it completely alone in every sense. At Men’s Health, we’re using this period… Read More »
Doctors use trigger point injections to treat chronic muscle pain and other issues that affect the musculoskeletal system. Muscle pain can develop for a variety of reasons, from sleeping in the wrong position to tearing large muscle groups during an intense weightlifting session. Although many types of muscle pain resolve after a few days of… Read More »
After his surprise removal from the Department of Health and Human Services’ (HHS’) Biomedical Advanced Research and Development Authority (BARDA)—a key agency partnered with pharma companies on COVID-19 drugs, vaccines and diagnostics—former Director Rick Bright is alleging whistleblower retaliation by HHS leadership. In an 89-page complaint published by The New York Times, Bright says he was “involuntarily… Read More »